Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.

Autor: Lockwood CM; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington; Brotman Baty Institute for Precision Medicine, Seattle, Washington. Electronic address: tinalock@uw.edu., Borsu L; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Cankovic M; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, Michigan., Earle JSL; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, Connecticut; Hartford Pathology Associates, Hartford, Connecticut., Gocke CD; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Hameed M; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Jordan D; Association for Molecular Pathology, Rockville, Maryland., Lopategui JR; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California., Pullambhatla M; Association for Molecular Pathology, Rockville, Maryland., Reuther J; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Invitae, San Francisco, California., Rumilla KM; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Tafe LJ; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Temple-Smolkin RL; Association for Molecular Pathology, Rockville, Maryland., Terraf P; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Tsimberidou AM; Liquid Biopsy Working Group of the Clinical Practice Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Investigational Cancer Therapeutics, Unit 455, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publikováno v: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2023 Dec; Vol. 25 (12), pp. 876-897. Date of Electronic Publication: 2023 Oct 06.

An Unexpected Diagnosis Uncovered by Quantitative Molecular Findings: A Case Report.

Autor: Buglioni A; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Guo R; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Rumilla KM; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Edgar MA; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida., Markovic SN; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., Zheng G; Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2023 Aug; Vol. 21 (8), pp. 787-791.

RNA-Seq Reveals Differences in Expressed Tumor Mutation Burden in Colorectal and Endometrial Cancers with and without Defective DNA-Mismatch Repair.

Autor: DiGuardo MA; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Davila JI; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; Department of Mathematics, Statistics, and Computer Science, St. Olaf College, Northfield, Minnesota., Jackson RA; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Nair AA; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Fadra N; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Minn KT; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Atiq MA; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Zarei S; Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio., Blommel JH; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Knight SM; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Jen J; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Eckloff BW; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Voss JS; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Rumilla KM; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Kerr SE; Hospital Pathology Associates, Minneapolis, Minnesota., Lam-Himlin DM; Department of Laboratory Medicine and Pathology, Divisions of Laboratory Genetics and Experimental Pathology, and Health Sciences Research, Mayo Clinic, Phoenix, Arizona., Bellizzi AM; Holden Comprehensive Cancer Center, Department of Pathology, University of Iowa, Iowa City, Iowa., Graham RP; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Kipp BR; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Jenkins RB; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Halling KC; Division of Laboratory Genetics and Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: halling.kevin@mayo.edu.

Publikováno v: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2021 May; Vol. 23 (5), pp. 555-564. Date of Electronic Publication: 2021 Feb 04.

An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.

Autor: Bible KC; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Menefee ME; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Jacksonville, Florida, USA., Lin CJ; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Millward MJ; Department of Medical Oncology, University of Western Australia, Perth, Australia., Maples WJ; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Jacksonville, Florida, USA., Goh BC; Division of Medical Oncology, National University Cancer Institute, Singapore, Singapore., Karlin NJ; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, Arizona, USA., Kane MA; Department of Medical Oncology, University of Colorado, Denver, Colorado, USA., Adkins DR; Division of Medical Oncology, Department of Medicine, Washington University, St. Louis, Missouri, USA., Molina JR; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Donehower RC; Division of Medical Oncology, Department of Medicine, Johns Hopkins, Baltimore, Maryland, USA., Lim WT; Division of Medical Oncology, National University Cancer Institute, Singapore, Singapore., Flynn PJ; Minnesota Oncology, Minneapolis, Minnesota, USA., Richardson RL; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Traynor AM; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA., Rubin J; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., LoRusso PM; Department of Oncology, Wayne State University, Detroit, Michigan, USA., Smallridge RC; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Jacksonville, Florida, USA., Burton JK; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Suman VJ; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Kumar A; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Voss JS; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Rumilla KM; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Kipp BR; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Chintakuntlawar AV; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Harris P; Cancer Therapy Evaluation Program (CTEP), Bethesda, Maryland, USA., Erlichman C; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.

Publikováno v: Thyroid : official journal of the American Thyroid Association [Thyroid] 2020 Sep; Vol. 30 (9), pp. 1254-1262. Date of Electronic Publication: 2020 Jul 29.